title: Rivaroxaban presents a better pharmacokinetic profile than dabigatran in an obese non-diabetic stroke patient.
authors.affiliation: Stroke Unit, Department of Neurology, Brugmann University Hospital, Brussels, Belgium. Electronic address: safouris@yahoo.com.
authors.forename: Apostolos
authors.initials: A
authors.lastname: Safouris
authors.affiliation: Hematology Department, Brugmann University Hospital, Brussels, Belgium.
authors.forename: Anne
authors.initials: A
authors.lastname: Demulder
authors.affiliation: First Department of Neurology, University of Athens, School of Medicine, "Eginition" University Hospital, Athens, Greece.
authors.forename: Nikos
authors.initials: N
authors.lastname: Triantafyllou
authors.affiliation: Second Department of Neurology, University of Athens, School of Medicine, "Attikon" University Hospital, Athens, Greece; International Clinical Research Center, St. Anne's University Hospital in Brno, Czech Republic.
authors.forename: Georgios
authors.initials: G
authors.lastname: Tsivgoulis
mesh_terms: D000368:Aged; D000991:Antithrombins / Q000493:pharmacokinetics* / Q000627:therapeutic use; D001562:Benzimidazoles / Q000493:pharmacokinetics* / Q000627:therapeutic use; D000069604:Dabigatran; D006801:Humans; D008297:Male; D009025:Morpholines / Q000493:pharmacokinetics* / Q000627:therapeutic use; D000069552:Rivaroxaban; D020521:Stroke / Q000517:prevention & control*; D013876:Thiophenes / Q000493:pharmacokinetics* / Q000627:therapeutic use; D015091:beta-Alanine / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use
chemical_list: D000991:Antithrombins; D001562:Benzimidazoles; D009025:Morpholines; D013876:Thiophenes; D015091:beta-Alanine; D000069552:Rivaroxaban; D000069604:Dabigatran